UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals... Show more
UBS Group AG stands as a leading global financial services firm, bolstered by its 2023 acquisition of Credit Suisse, which has expanded its wealth management franchise and investment banking capabilities. The combined entity now ranks among the top wealth managers worldwide, with competitive advantages in cross-border services, particularly in high-growth regions like Asia. Medium-term positioning emphasizes sustainable growth in AUM, diversification into fee-based revenues, and efficiency gains from integration. UBS targets long-term ambitions of approximately 18% RoCET1 (return on common equity tier 1 capital) and a 67% cost/income ratio by 2028, driven by streamlined operations and strategic focus on high-return businesses. While facing competition from U.S. giants like JPMorgan and European peers, UBS's Swiss stability, global footprint, and post-merger scale provide a robust platform for market share gains in wealth management and advisory services.
The most pivotal near-term event is the Q1 2026 earnings release on April 29, where investors will scrutinize progress on cost synergies, NII trajectory amid potential rate normalization, and updates on Credit Suisse client migrations—nearly complete with 950,000 clients transitioned. Subsequent quarters (Q2 on July 29, Q3 on October 28) will track integration completion by year-end, a milestone Fitch Ratings highlighted in its recent A+ upgrade, citing diminished execution risk.
Capital allocation decisions, including a planned $3 billion share repurchase program and mid-teens dividend hike, could boost shareholder returns and sentiment. Analyst revisions have trended positive, with consensus ratings at Moderate Buy from 13 firms and an average price target of $60.30, suggesting over 45% upside; recent upgrades reflect optimism on profitability restoration. Regulatory clarity on legacy Credit Suisse issues and potential M&A (mergers and acquisitions) opportunities further shape the outlook.
UBS's business model is highly sensitive to interest rates, with NII benefiting from higher-for-longer environments but facing pressure from anticipated central bank cuts in 2026. Wealth management fees, tied to AUM, stand to gain from equity rallies driven by AI and tech themes, while investment banking revenues hinge on M&A and IPO activity amid improving liquidity. Broader forces include resilient global growth forecasts, commodity price rises supporting trading desks, and geopolitical risks impacting cross-border flows. Regulatory scrutiny in banking, including capital requirements (CET1 - common equity tier 1), remains key, but UBS's strong balance sheet positions it well. Inflation moderation and technology adoption in fintech could enhance margins long-term.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments, including searchable categories, historical context, and alert functionality. This innovative resource empowers users to make informed decisions by leveraging advanced pattern recognition and machine learning. Discover the Trend Prediction Engine today.
Heading into 2026, UBS anticipates restoring pre-acquisition profitability levels while advancing Credit Suisse integration to capture full synergies by year-end. Structural drivers include AUM expansion in Asia, cost discipline targeting sub-70% cost/income, and ROTCE improvement toward 2028 goals of 18%. Technology transitions like AI integration in advisory services and sustainable finance offer growth avenues, alongside capital priorities favoring buybacks and dividends. Competitive threats from fintech disruptors and regulatory evolution, such as Basel III endgame, warrant monitoring. Consensus analyst expectations project 2026 revenues around $51 billion, reflecting modest 4% growth, with sentiment buoyed by efficiency gains. Long-term themes center on diversified revenue streams mitigating rate volatility and positioning UBS as a premier universal bank.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a major bank
Industry MajorBanks
A.I.dvisor indicates that over the last year, UBS has been loosely correlated with ING. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if UBS jumps, then ING could also see price increases.
| Ticker / NAME | Correlation To UBS | 1D Price Change % | ||
|---|---|---|---|---|
| UBS | 100% | +1.62% | ||
| ING - UBS | 65% Loosely correlated | +1.79% | ||
| BCS - UBS | 63% Loosely correlated | +2.91% | ||
| SAN - UBS | 57% Loosely correlated | +2.47% | ||
| HSBC - UBS | 55% Loosely correlated | +2.15% | ||
| SMFG - UBS | 51% Loosely correlated | +2.43% | ||
More | ||||
The 50-day moving average for UBS moved above the 200-day moving average on May 18, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Momentum Indicator moved above the 0 level on June 11, 2026. You may want to consider a long position or call options on UBS as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UBS advanced for three days, in of 340 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 304 cases where UBS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for UBS moved out of overbought territory on May 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 53 cases where UBS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for UBS turned negative on May 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
UBS broke above its upper Bollinger Band on June 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 24, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.740) is normal, around the industry mean (1.823). P/E Ratio (17.552) is within average values for comparable stocks, (14.944). UBS's Projected Growth (PEG Ratio) (0.888) is slightly lower than the industry average of (1.669). Dividend Yield (0.023) settles around the average of (0.025) among similar stocks. P/S Ratio (3.257) is also within normal values, averaging (3.878).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.